Skip to main content
. 2021 Sep 8;188:106606. doi: 10.1016/j.rmed.2021.106606

Table 2.

Outcomes in the two cohorts of COVID-19 patients with and without cystic fibrosis before and after propensity score matching.

Outcome Cystic Fibrosis cohort (n = 422) Percentage Non-CF cohort (n = 507,388) Percentage Risk Ratio 95% CI Lower 95% CI Upper
Before propensity score matching
30-day Mortality 22 5.21 8,705 1.72 3.74 2.02 4.57
Inpatient services 117 27.73 39,471 7.78 3.56 3.05 4.16
Critical Care 49 11.61 12,953 2.55 4.55 3.49 5.92
Mechanical ventilation 26 6.16 7,842 1.55 3.99 2.75 5.79
30-day composite outcome 37 8.77 13,288 2.62 3.35 2.46 4.56
Acute renal injury 60 14.22 19,646 3.87 3.67 2.90 4.64
Outcome Cystic Fibrosis cohort (n=413) Percentage Non-CF cohort (n=413) Percentage Risk Ratio 95% CI Lower 95% CI Upper
After propensity score matching
30-day Mortality 22 5.33 12 2.91 1.83 0.92 3.66
Inpatient services 111 26.88 71 17.19 1.56 1.20 2.04
Critical Care 48 11.62 27 6.54 1.78 1.13 2.79
Mechanical ventilation 26 6.30 17 4.12 1.53 0.84 2.78
30-day composite outcome 37 8.96 23 5.57 1.61 0.97 2.66
Acute renal injury 56 13.56 35 8.48 1.60 1.07 2.39

Abbreviation: CF: Cystic Fibrosis, CI: Confidence Interval.